Plus Therapeutics (PSTV) Stock Chart & Stock Price History $1.09 +0.10 (+10.10%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Plus Therapeutics Stock Price Performance 5 Day Performance-6.84%1 Month Performance-9.17%3 Month Performance-33.54%6 Month Performance-39.44%Year-To-Date Performance-37.72%1 Year Performance-42.33% Receive PSTV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Plus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address The #1 Coin for November 2024 (Ad)Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide… You can get access to the report by clicking here now… PSTV Stock Chart for Sunday, December, 22, 2024 PSTV Chart by TradingView Plus Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/20/2024$0.99$1.09+10.10%$1.11$0.9748,987 shs$6.43 million12/19/2024$1.00$0.99-1.00%$1.10$0.9384,106 shs$5.84 million12/18/2024$1.07$1.00-6.54%$1.10$0.9879,403 shs$5.90 million12/17/2024$1.17$1.07-8.55%$1.23$1.03282,543 shs$6.31 million12/16/2024$1.27$1.17-7.87%$1.28$1.1271,881 shs$6.90 million12/13/2024$1.33$1.27-4.51%$1.33$1.2232,346 shs$7.49 million Get the Latest News and Ratings for PSTV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Plus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/12/2024$1.35$1.33-1.48%$1.37$1.2693,367 shs$7.85 million12/11/2024$1.31$1.35+3.45%$1.36$1.3037,455 shs$7.97 million12/10/2024$1.36$1.31-4.04%$1.36$1.3045,526 shs$7.70 million12/09/2024$1.39$1.36-2.16%$1.41$1.3327,735 shs$8.02 million12/06/2024$1.34$1.39+3.73%$1.45$1.3279,460 shs$8.20 million12/05/2024$1.33$1.34+0.75%$1.40$1.3187,413 shs$7.91 million12/04/2024$1.34$1.33-0.75%$1.37$1.3225,770 shs$7.85 million12/03/2024$1.29$1.34+3.88%$1.41$1.30122,749 shs$7.91 million12/02/2024$1.28$1.29+0.78%$1.32$1.2430,364 shs$7.61 million11/29/2024$1.26$1.28+1.59%$1.31$1.2429,223 shs$7.55 million11/28/2024$1.26$1.26$1.28$1.2312,758 shs$7.43 million11/27/2024$1.28$1.26-1.56%$1.28$1.2312,758 shs$7.43 million11/26/2024$1.23$1.28+4.07%$1.33$1.2427,994 shs$7.55 million11/25/2024$1.18$1.23+4.24%$1.25$1.16115,082 shs$7.26 million11/22/2024$1.20$1.18-1.67%$1.22$1.12461,578 shs$6.96 million11/21/2024$1.19$1.20+0.84%$1.22$1.1626,954 shs$7.08 million11/20/2024$1.22$1.19-2.46%$1.24$1.1815,757 shs$7.02 million Related Companies Femasys Stock Chart Co-Diagnostics Stock Chart DarioHealth Stock Chart Vivos Therapeutics Stock Chart Allurion Technologies Stock Chart NeurAxis Stock Chart Microbot Medical Stock Chart Nephros Stock Chart Innovative Eyewear Stock Chart ReWalk Robotics Stock Chart Receive PSTV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Plus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PSTV) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredMUST SEE: The most important video in the world right now?If you have a significant amount of money in the stock market right now — or if you're sitting on the sideline...InvestorPlace | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Plus Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Plus Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
